实验室医学战略 - EFLM 愿景 实验室医学战略
Mario Plebani1, Tomas Zima2, Damien Gruson3
1Department of Medicine-DIMED, University of Padova, Padova, Italy.
Clinical chemistry and laboratory medicine
|December 29, 2025
概括
欧洲临床化学和实验室医学联合会 (EFLM) 正在更新其战略,以领导精确诊断和数字医疗保健. EFLM优先考虑以患者为中心,数据驱动的实验室医学,以改善全球健康结果.
科学领域:
- 临床化学 临床化学
- 实验室医学 实验室医学
- 医疗保健转型 医疗保健转型
背景情况:
- 全球医疗保健趋势,技术进步和实验室专业人员不断变化的角色塑造了现代医学.
- 实验室医学对于准确,及时和具有成本效益的患者护理越来越重要.
- 欧洲临床化学和实验室医学联合会 (EFLM) 承认需要进行战略适应.
研究的目的:
- 将实验室医学定位为精密诊断,数字医疗保健和综合诊断领域的领导者.
- 确保实验室创新优先考虑患者的结果,公平的获取和对数据的信任.
- 引导诊断转变为以患者为中心,数据驱动和弹性护理模式.
主要方法:
- 专注于整合实验室创新和基于价值的实验室医学.
- 加强实验室专业人员的工作人员能力.
- 促进可持续性和改善临床结果.
主要成果:
- EFLM的战略强调以患者为中心的护理,数据驱动的洞察力和弹性诊断模型.
- 主要优先事项包括推进实验室创新,提高员工技能和提高可持续性.
- 该战略旨在加强实验室医学对临床护理和公共卫生的影响.
结论:
- 实验室医学必须不断发展,以应对全球挑战和技术进步.
- 以患者为中心,数据驱动和弹性诊断方法是必不可少的.
- EFLM的战略方向将加强实验室医学在改善患者结果和科学进步方面的作用.
相关概念视频
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...